Literature DB >> 1870201

Spleen necrosis virus, an avian retrovirus, can infect primate cells.

H M Koo1, A M Brown, Y Ron, J P Dougherty.   

Abstract

Spleen necrosis virus (SNV) is an avian retrovirus that can infect some mammalian cells such as dog cells as well as all avian cells tested to date. We were interested in testing whether SNV could also infect primate cells. For these experiments, we used HeLa and COS-7 cells. Initially, we determined whether the SNV long terminal repeat promoter was functional in HeLa and COS-7 cells. In transient transfection assays, the SNV promoter efficiently directed chloramphenicol acetyltransferase gene expression in both HeLa and COS-7 cells. Using SNV- and murine leukemia virus-derived retroviral vectors containing the neomycin phosphotransferase gene, we found that SNV established a provirus in HeLa and COS-7 cells as efficiently as did an amphotropic murine leukemia virus, as judged by the number of G418-resistant HeLa and COS-7 cell colonies obtained after infection and selection. Although SNV formed a provirus in both HeLa and COS-7 cells, productive infection of these cells was not obtained with use of replication-competent SNV. These results suggest that SNV can infect, form a provirus, and stably express a transduced gene in primate cells, but there is a posttranscriptional block to its replication in these cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1870201      PMCID: PMC248934     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

2.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors:  S Goff; P Traktman; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

3.  Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5.

Authors:  E Beck; G Ludwig; E A Auerswald; B Reiss; H Schaller
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

4.  Expression from an internal AUG codon of herpes simplex thymidine kinase gene inserted in a retrovirus vector.

Authors:  P K Bandyopadhyay; H M Temin
Journal:  Mol Cell Biol       Date:  1984-04       Impact factor: 4.272

5.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

Authors:  M Boshart; F Weber; G Jahn; K Dorsch-Häsler; B Fleckenstein; W Schaffner
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

6.  Receptor interference groups of 20 retroviruses plating on human cells.

Authors:  M A Sommerfelt; R A Weiss
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

7.  High mutation rate of a spleen necrosis virus-based retrovirus vector.

Authors:  J P Dougherty; H M Temin
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

8.  Prospects for human gene therapy.

Authors:  W F Anderson
Journal:  Science       Date:  1984-10-26       Impact factor: 47.728

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors.

Authors:  S Watanabe; H M Temin
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

View more
  12 in total

1.  Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells.

Authors:  R Gautier; A Jiang; V Rousseau; R Dornburg; T Jaffredo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Vectors derived from avian leukosis and sarcoma viruses.

Authors:  F Flamant; F L Cosset; J Samarut
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

3.  Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer.

Authors:  T H Chu; R Dornburg
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  The RD114/simian type D retrovirus receptor is a neutral amino acid transporter.

Authors:  J E Rasko; J L Battini; R J Gottschalk; I Mazo; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions.

Authors:  Mariana Marin; Dimitri Lavillette; Sean M Kelly; David Kabat
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  In vivo study of genetically simplified bovine leukemia virus derivatives that lack tax and rex.

Authors:  K Boris-Lawrie; V Altanerova; C Altaner; L Kucerova; H M Temin
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Interclass transmission and phyletic host tracking in murine leukemia virus-related retroviruses.

Authors:  J Martin; E Herniou; J Cook; R W O'Neill; M Tristem
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Mapping of receptor binding domains in the envelope protein of spleen necrosis virus.

Authors:  I Martinez; R Dornburg
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Germline transmission of exogenous genes in chickens using helper-free ecotropic avian leukosis virus-based vectors.

Authors:  P Thoraval; M Afanassieff; F L Cosset; F Lasserre; G Verdier; F Coudert; G Dambrine
Journal:  Transgenic Res       Date:  1995-11       Impact factor: 2.788

10.  Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group.

Authors:  H M Koo; J Gu; A Varela-Echavarria; Y Ron; J P Dougherty
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.